Skip to main content
. 2022 Mar 22;9:850844. doi: 10.3389/fsurg.2022.850844

Table 1.

Baseline characteristics of studies included in the meta-analysis.

First author Study type Year Number Age Sex, M/F ASA I/II/III/IV Malignant/Benign Mortality
ERAS TC ERAS TC ERAS TC ERAS TC ERAS TC ERAS TC
Jan H. Stoot CCT 2009 13 13 55 (34–82) 45 (26–70) 3/10 2/11 3/9/1/0 6/6/1/0 5/8 2/11 0 0
Belinda Sánchez-Pérez CCT 2012 26 17 58.3 (29–77) 52.5 (29–84) 15/11 10/7 0/13/13/0 0/9/8/0 12/14 3/14 0 0
F He RCT 2015 48 38 56.3 ± 16.3 60.4 ± 20.7 22/26 18/20 10/26/2/0 12/24/2/0 31/17 24/14 0 0
Xiao Liang RCT 2016 80 107 53.4 ± 13.5 55.5 ± 12.8 37/43 50/57 35/45/0/0 49/58/0/0 51/29 55/52 0 0
Yuan Ding CCT 2018 49 133 56.04 ± 11.50 56.31 ± 11.57 31/18 88/45 NR NR 33/16 99/34 0 0
Xiao Liang RCT 2018 58 61 58 (16–80) 59 (37–85) 25/33 22/39 12/35/11 8/48/5/0 29/29 44/17 0 0

ASA, American Society of Anesthesiologists; CCT, case control study; ERAS, enhanced recovery after surgery; F, female; M, male; NR, not reported; RCT, randomized clinical trial; TC, traditional care.